<DOC>
	<DOCNO>NCT02324699</DOCNO>
	<brief_summary>Use co-induction corticosteroid therapy may accelerate remission rate use vedolizumab . Further , may lead high rate response remission week 10 would see vedolizumab monotherapy .</brief_summary>
	<brief_title>Corticosteroids With Vedolizumab Crohn 's Disease</brief_title>
	<detailed_description>This study examine prednisone co-induction vedolizumab patient Crohn 's disease . To address question regard effect co-induction mucosal healing , study include colonoscopic assessment mucosal healing . Finally , colonic biopsy study allow elucidate mechanism action vedolizumab Crohn 's disease immune phenotyping study .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vedolizumab</mesh_term>
	<criteria>Age entry 18 70 CDAI score &gt; 220 Concomitant azathioprine , methotrexate , mercaptopurine permit dose stable &gt; 8 week . Prior antiTNFα antibody use permit must discontinue ( &gt; 2 week last dose ) prior initiation vedolizumab . Documented ulceration colonoscopy do screen 3 large ulcer 10 aphthous ulcer Able provide write informed consent . Patient plan eligible initiate vedolizumab Concurrent use antiTNFα antibody . No corticosteroid within prior 3 month ( budesonide control ileal release ) No stoma time enrollment No absolute contraindication systemic corticosteroid use hypersensitivity part formulation , systemic fungal infection , recent administration live live attenuate vaccine within prior two week . Pregnant woman plan pregnancy within 3 month study inclusion Presence stoma , three smallbowel resection , document history short bowel syndrome Intestinal stricture require surgery Abdominal abscess Inability unwillingness provide inform consent Any condition , , opinion investigator would impede competence compliance possibly hinder completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Vedolizumab</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Crohn 's disease</keyword>
</DOC>